OBBI

Multidisciplinary expertise in biomanufacturing

OBBI draws on advanced know-how in the bioproduction of EVs and organoids, as well as in the implementation of standardised processes that comply with Good Manufacturing Practice (GMP). Thanks to the synergy between the research teams in Toulouse and Montpellier, OBBI is able to offer an integrated solution to the most complex scientific and industrial challenges.

Expertise in quality control and standardisation

OBBI excels in the implementation of high-resolution quality controls to guarantee the reproducibility and industrialisation of processes. These activities include advanced characterisation of cells, whether mature or progenitor, generating organoids or producing EVs, and of the 3D objects themselves, meeting the strict requirements of the pharmaceutical industry and regulatory agencies.

Collaborative, cross-disciplinary expertise

With its collaborative and integrated governance, OBBI facilitates interactions between academic and industrial partners. Its strategic collaborations with key industrial players enable it to bridge the gap between fundamental research and industrial applications. Thanks to its expertise, OBBI offers solutions to help validate and industrialise bio-therapeutic innovations, while guaranteeing quality and reproducibility in line with industrial requirements.

Infrastructures of excellence and network

Based in the Occitanie region, OBBI is part of a very dynamic industrial and academic ecosystem, with many researchers and clinicians in Montpellier and Toulouse who have been working in the field of biotherapies for several years and have acquired expertise and complementary skills in biomanufacturing. OBBI proposes to capitalise on this know-how by making it available to players in industry and academia, with the shared aim of providing innovative solutions for tomorrow’s treatments. Through these players, OBBI also interacts closely with national networks in the field (PEPR, GDR organoïdes, France Biolead, FSEV, EVOLVE) as well as European partners.

A strategic position in the Occitanie region and nationally

OBBI draws on the region’s ecosystem of academic and business structures in the field of biotherapies, bioproductions and regenerative medicine, which has been identified as a major cluster at national level. By integrating local skills and existing infrastructures, OBBI will play a key role in the national and European landscape of organoid and EV bioproduction, with the aim of encouraging the emergence of technological innovations and public-private partnerships.